| |
| |
|
| Insider
Information: |
Gershell Leland |
| Relationship: |
CHIEF FINANCIAL OFFICER |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
21,360 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,928 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
21,360 |
|
|
| Total
Value |
$3,928 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tonix Pharmaceuticals Holding Corp |
TNXP |
Chief Financial Officer |
2015-09-28 |
19,260 |
|
0 |
Premium* |
|
|
Capricor Therapeutics |
CAPR |
CHIEF FINANCIAL OFFICER |
2016-03-16 |
2,100 |
2016-03-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CAPR |
Capricor Therapeutics |
CHIEF FINANCIAL OFFICER |
• – – |
2016-03-16 |
4 |
B |
$2.40 |
$5,040 |
D/D |
2,100 |
2,100 |
2.74 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Financial Officer |
• – – |
2015-09-28 |
4 |
B |
$5.83 |
$2,330 |
D/D |
400 |
19,260 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Financial Officer |
• – – |
2015-07-17 |
4 |
B |
$7.50 |
$7,500 |
D/D |
1,000 |
18,860 |
2.74 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Financial Officer |
• – – |
2015-02-09 |
4 |
B |
$5.85 |
$29,250 |
D/D |
5,000 |
17,860 |
2.74 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Financial Officer |
• – – |
2014-12-17 |
4 |
OE |
$4.25 |
$15,003 |
D/D |
3,530 |
12,860 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
CFO and Treasurer |
• – – |
2013-09-06 |
4 |
B |
$3.40 |
$1,700 |
D/D |
500 |
9,330 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
CFO and Treasurer |
• – – |
2013-08-14 |
4 |
B |
$0.00 |
$0 |
D/D |
3,530 |
8,830 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
CFO and Treasurer |
• – – |
2013-05-24 |
4 |
B |
$7.49 |
$1,124 |
D/D |
150 |
5,300 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
CFO and Treasurer |
• – – |
2013-05-23 |
4 |
B |
$7.49 |
$375 |
D/D |
50 |
5,150 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
CFO and Treasurer |
• – – |
2013-05-21 |
4/A |
B |
$7.49 |
$749 |
D/D |
100 |
5,100 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
CFO and Treasurer |
• – – |
2013-05-21 |
4 |
B |
$7.49 |
$749 |
D/D |
100 |
100,100 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
CFO and Treasurer |
• – – |
2013-04-26 |
4 |
OE |
$0.40 |
$15,000 |
D/D |
37,500 |
100,000 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Financial OfficerOfficer |
• – – |
2013-01-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
62,500 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
